(Q37781728)

23 August 2017

title

A review of malignant meningiomas: diagnosis, characteristics, and treatment (English)

1 reference

23 August 2017

0 references

Simon Hanft

1

1 reference

23 August 2017

Peter Canoll

series ordinal

2

1 reference

23 August 2017

Jeffrey N. Bruce

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20730473

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20730473

21 June 2024

publication date

21 August 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11060-010-0348-9.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S11060-010-0348-9

http://link.springer.com/article/10.1007/s11060-010-0348-9/fulltext.html

21 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0348-9

http://link.springer.com/content/pdf/10.1007/s11060-010-0348-9

21 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11060-010-0348-9

Journal of Neuro-Oncology

21 June 2024

published in

1 reference

23 August 2017

volume

99

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

433-443

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-010-0348-9

23 August 2017

exact match

0 references

cites work

Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0348-9

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0348-9

Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0348-9

Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0348-9

Role of diffusion tensor imaging in differentiating subtypes of meningiomas.

21 January 2018

1 reference

12 December 2020

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

1 reference

12 December 2020

A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas

1 reference

12 December 2020

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy

1 reference

12 December 2020

Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature

1 reference

12 December 2020

p14ARF links the tumour suppressors RB and p53.

1 reference

12 December 2020

Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.

1 reference

12 December 2020

Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation

1 reference

12 December 2020

Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma

1 reference

12 December 2020

Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.

1 reference

12 December 2020

Targeted drug therapy for meningiomas

1 reference

12 December 2020

Radiotherapy for atypical or malignant intracranial meningioma.

1 reference

12 December 2020

Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers

1 reference

12 December 2020

Diagnosis and treatment of atypical and anaplastic meningiomas: a review

1 reference

12 December 2020

The 2007 WHO classification of tumours of the central nervous system

1 reference

12 December 2020

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue

1 reference

12 December 2020

The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas.

1 reference

12 December 2020

Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy

1 reference

12 December 2020

Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging.

1 reference

12 December 2020

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

1 reference

12 December 2020

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

1 reference

12 December 2020

New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma

1 reference

12 December 2020

Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.

1 reference

12 December 2020

WHO grade II and III meningiomas: a study of prognostic factors.

1 reference

12 December 2020

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

1 reference

12 December 2020

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy

1 reference

12 December 2020

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.

1 reference

12 December 2020

Do aggressive imaging features correlate with advanced histopathological grade in meningiomas?

1 reference

12 December 2020

Stereotactic radiation treatment for recurrent nonbenign meningiomas.

1 reference

12 December 2020

Review of meningioma histopathology

1 reference

12 December 2020

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

1 reference

12 December 2020

Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.

1 reference

12 December 2020

Loss of heterozygosity studies in extracranial metastatic meningiomas.

1 reference

12 December 2020

Histological classification and molecular genetics of meningiomas

1 reference

12 December 2020

Identifiers

DOI

1 reference

23 August 2017

1 reference